You must log in to view this page.

Neurogene Inc.

NASDAQ: NGNE
Share price (1/9/26): $17.92
Market cap (1/9/26): $278 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

EX-1

from SCHEDULE 13G ~1 page Joint Filing Agreement

12/34/56

EX-1

from SCHEDULE 13G/A 1 page Joint Filing Agreement

12/34/56

EX-1.1

from 10-Q 40 pages Neurogene Inc. Shares of Common Stock ($0.000001 Par Value Per Share) Sales Agreement

12/34/56

EX-1.1

from 8-K 29 pages Neoleukin Therapeutics, Inc. Common Stock ($0.000001 Par Value) Atm Equity Offeringsm Sales Agreement

12/34/56

EX-1.1

from 8-K 35 pages 3,262,471 Shares of Common Stock and Pre-Funded Warrants to Purchase 1,737,529 Shares of Common Stock Neoleukin Therapeutics, Inc. Underwriting Agreement July 1, 2020

12/34/56

EX-1.1

from 8-K 38 pages 8,925,000 Shares of Common Stock Neoleukin Therapeutics, Inc. Underwriting Agreement December 17, 2019

12/34/56

EX-1.1

from 8-K 38 pages 5,350,000 Shares Aquinox Pharmaceuticals, Inc. Common Stock, Par Value $0.000001 Per Share Underwriting Agreement September 19, 2016

12/34/56

EX-1.1

from 8-K 39 pages 5,500,000 Shares Aquinox Pharmaceuticals, Inc. Common Stock, Par Value $0.000001 Per Share Underwriting Agreement September 9, 2015

12/34/56

EX-1.1

from 8-K 32 pages Aquinox Pharmaceuticals, Inc. $25,000,000 Sales Agreement

12/34/56

EX-1.1

from S-1/A 45 pages [—] Shares Aquinox Pharmaceuticals, Inc. Underwriting Agreement

12/34/56

Neurogene Inc. Watch

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

Neurogene Inc.